These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9698715)

  • 21. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Jefferys RJ
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16116145
    [No Abstract]   [Full Text] [Related]  

  • 22. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical considerations in anticonvulsant therapy--Part 2.
    Meyer MC; Cloyd J; Garnett WR; Holmes GL; Schiffer JR
    Am Pharm; 1995 Sep; NS35(9):31-6, 40. PubMed ID: 7484814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients.
    Tobler A; Mühlebach S
    Int J Clin Pharm; 2013 Oct; 35(5):790-7. PubMed ID: 23812678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH; Mehla J; Pahuja M; Gupta YK
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Perron R
    Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15858865
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy.
    Nicolazzo JA; Steuten JA; Charman SA; Taylor N; Davies PJ; Petrou S
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):647-9. PubMed ID: 20082623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizure management at Auckland City Hospital Emergency Department between July and December 2009: time for a change?
    Rosemergy I; Bergin P; Jones P; Walker E
    Intern Med J; 2012 Sep; 42(9):1023-9. PubMed ID: 22530623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching between phenytoin generics in patients with epilepsy may lead to increased risk of breakthrough seizure: chart analysis and practice recommendations.
    Shin JW; Chu K; Jung KH; Lee ST; Moon J; Lee SK
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1017-22. PubMed ID: 25295717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures.
    ;
    Ann Emerg Med; 2004 May; 43(5):605-25. PubMed ID: 15111920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka.
    Kariyawasam SH; Bandara N; Koralagama A; Senanayake S
    Neurol India; 2004 Jun; 52(2):233-7. PubMed ID: 15269479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic.
    Ioannides-Demos LL; Horne MK; Tong N; Wodak J; Harrison PM; McNeil JJ; Gilligan BS; McLean AJ
    Am J Hosp Pharm; 1988 Jul; 45(7):1549-51. PubMed ID: 3046349
    [No Abstract]   [Full Text] [Related]  

  • 33. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A; Hashimoto Y; Takayanagi K; Otsuki Y; Koue T; Takano M; Yasuhara M; Hattori H; Furusho K; Inui K
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Burkhardt RT; Leppik IE; Blesi K; Scott S; Gapany SR; Cloyd JC
    Neurology; 2004 Oct; 63(8):1494-6. PubMed ID: 15505173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic drugs in developing countries.
    Trevathan E; Medina MT; Madrid A
    Lancet; 1998 Apr; 351(9110):1210-1. PubMed ID: 9643725
    [No Abstract]   [Full Text] [Related]  

  • 36. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.
    Browne TR; Szabo GK; Leppik IE; Josephs E; Paz J; Baltes E; Jensen CM
    J Clin Pharmacol; 2000 Jun; 40(6):590-5. PubMed ID: 10868309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fosphenytoin: pharmacokinetics and tolerance of intramuscular loading doses.
    Pryor FM; Gidal B; Ramsay RE; DeToledo J; Morgan RO
    Epilepsia; 2001 Feb; 42(2):245-50. PubMed ID: 11240597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
    Sirmagul B; Atli O; Ilgin S
    Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.
    Pattanaik S; Hota D; Prabhakar S; Kharbanda P; Pandhi P
    Phytother Res; 2006 Aug; 20(8):683-6. PubMed ID: 16767797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.